Leishmaniasis

Leishmaniasis is a disease caused by parasites of the Leishmania type. It is spread by the bite of certain types of sandflies, and occurs most frequently in the tropics and sub-tropics of Africa, Asia, the Americas, and southern Europe. The disease can present in three main ways: cutaneous, mucocutaneous, or visceral. The cutaneous form presents with skin ulcers, while the mucocutaneous form presents with ulcers of the skin, mouth, and nose. The visceral form starts with skin ulcers and later presents with fever, low count of red blood cells, and enlarged spleen and liver.Infections in humans are caused by more …

Wikipedia

Publications

WHO: World Health Organization · 15 December 2024 French

24 p

99, 653–676 No 45 653 Contents 653 Global leishmaniasis surveillance updates 2023: 3 years of the (HSI-TAG): résumé de la réunion annuelle Global leishmaniasis surveillance updates 2023: 3 years of the Abate Beshahe and José Antonio Ruiz-Postigoa Leishmaniasis continues to be a major health problem in 4 and South- East Asia.1 This report on global leishmaniasis surveillance follows those published in 2016–2023 report are to update the description of the GHO leishmaniasis indicators reported by Member States to WHO


WHO: World Health Organization · 13 November 2024 English

[‎iv]‎, 18 p.

1 mg or 1.5 mg ODT Moxidectin ODF Visceral leishmaniasis Miltefosine 20 mg SDT LXE408 Amphotericin B


WHO: World Health Organization · 8 November 2024 French

17 p

653 Global leishmaniasis surveillance updates 2023: 3 years of the NTD road map Saurabh Jain,a Serge Abate Beshahe and José Antonio Ruiz-Postigoa Leishmaniasis continues to be a major health problem in 4 and South- East Asia.1 This report on global leishmaniasis surveillance follows those published in 2016–2023 report are to update the description of the GHO leishmaniasis indicators reported by Member States to WHO for cutaneous leish- maniasis (CL), visceral leishmaniasis (VL) and VL treatment outcomes, VL case fatal-


WHO: World Health Organization · 6 November 2024 English

12 p.

(HAT), scabies, onchocerciasis and visceral leishmaniasis (VL). KEY MESSAGES More than 1 billion people all age groups) focused on three diseases: leishmaniasis (40; 33%), dengue (19; 16%) and leprosy (13; trials recruiting children, most were focused on leishmaniasis (11; 21%). Dengue and schistosomiasis have 76 Phase 4 36 Unknown or not applicable 57 Leishmaniasis (75 medicines) Phase 2 4 Phase 3 6 Phase 4 7 scabies and onchocerciasis, and visceral leishmaniasis (9). Table 1 below lists the priority and watch


WHO: World Health Organization · 1 November 2024 French

12 p

internationaux et santé Leishmaniasis https://www.who.int/health-topics/leishmaniasis#tab=tab_1 Leishmaniose


EU: European Union · 29 October 2024 English

The conference exhibition will consist of 52 posters which will be available for viewing in a dedicated space adjacent to the coffee/lunch tables.

climatically suitable European regions for leishmaniasis to guide public health interventions . . . Witwatersrand, Johannesburg, South Africa 8Abstract Leishmaniasis is a climate-sensitive zoonotic disease caused sand flies. Zoonotic visceral leishmaniasis (VL) and cutaneous leishmaniasis (CL) caused by Leishmania approach to track the climatic suitability for leishmaniasis at sub-national level across Europe over two (2001-2010 and 2011- 2020). We compiled records of leishmaniasis cases caused by Leishmania infantum (ECDC)


ICIPE: African Insect Science for Food and Health · 18 October 2024 English

Started in 2015, the GBS series brings together Indeed, the ReSAKSS 2024 Annual Trends experts and stakeholders from all hemispheres and and Outlook Report (ATOR), titled ‘Advancing backgrounds, representing the …

implementation of a pathogenesis of Visceral Leishmaniasis Collaborators: FORESTED; Sustainable transformative TechnoServe malaria control in Africa using symbiont- leishmaniasis (PKDL) in Eastern Africa based transmission


WHO: World Health Organization · 13 October 2024 English

Plague Leptospirosis Landslide Hepatitis A Leishmaniasis Crimean-Congo haemorrhagic fever Hepatitis E 30-Jul-24 54 4 7.4% Since January 2024, Visceral Leishmaniasis cases have been reported in Kitui and Mandera


WHO: World Health Organization · 6 October 2024 English

Plague Leptospirosis Landslide Hepatitis A Leishmaniasis Crimean-Congo haemorrhagic fever Hepatitis E 30-Jul-24 54 4 7.4% Since January 2024, Visceral Leishmaniasis cases have been reported in Kitui and Mandera


WHO: World Health Organization · 29 September 2024 English

Plague Leptospirosis Landslide Hepatitis A Leishmaniasis Crimean-Congo haemorrhagic fever Hepatitis E 30-Jul-24 54 4 7.4% Since January 2024, Visceral Leishmaniasis cases have been reported in Kitui and Mandera


View more